Jie Wang
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- Genomics and Chromatin Dynamics
- Retinal Development and Disorders
Papers in
-
- RNA modifications and cancer 25
- RNA Research and Splicing 12
- Epigenetics and DNA Methylation 12
- Cancer-related gene regulation 10
-
- Cancer-related molecular mechanisms research 26
- MicroRNA in disease regulation 19
- Co-authors
- Zhiping Weng (1 shared paper)Michael M. Hoffman (1 shared paper)William Stafford Noble (1 shared paper)Jeff Bilmes (1 shared paper)Orion J. Buske (1 shared paper)Weiping Zhou (4 shared papers)Shengxian Yuan (4 shared papers)Yuan Yang (3 shared papers)
- Journals
- Scientific Reports (4 papers)Nature Communications (4 papers)Cell Death and Disease (4 papers)Frontiers in Immunology (3 papers)Cancer Letters (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jie Wang
128 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 125
- Cancer Research 1.2k
- Molecular Biology 2.3k
- Ophthalmology 160
- Hepatology 138
- Immunology 275
Countries citing papers authored by Jie Wang
This map shows the geographic impact of Jie Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Wang more than expected).
Fields of papers citing papers by Jie Wang
This network shows the impact of papers produced by Jie Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Wang. The network helps show where Jie Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jie Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 376 | |
| 2 | 2015 | 335 | |
| 3 | 2017 | 148 | |
| 4 | 2018 | 111 | |
| 5 | 2015 | 99 | |
| 6 | 2012 | 88 | |
| 7 | 2014 | 84 | |
| 8 | 2020 | 61 | |
| 9 | 2015 | 50 | |
| 10 | 2022 | 50 | |
| 11 | 2019 | 49 | |
| 12 | 2021 | 48 | |
| 13 | 2021 | 48 | |
| 14 | 2021 | 47 | |
| 15 | 2016 | 45 | |
| 16 | 2022 | 44 | |
| 17 | 2017 | 43 | |
| 18 | 2022 | 41 | |
| 19 | 2020 | 36 | |
| 20 | 2019 | 35 |
About Jie Wang
Jie Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Ophthalmology, having authored 138 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (26 papers), RNA modifications and cancer (25 papers), MicroRNA in disease regulation (19 papers), Retinal Diseases and Treatments (15 papers), RNA Research and Splicing (12 papers), Epigenetics and DNA Methylation (12 papers), Immune cells in cancer (11 papers) and Cancer-related gene regulation (10 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (2.3k citations), Ophthalmology (160 citations), Hepatology (138 citations) and Immunology (275 citations). Jie Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhiping Weng, Michael M. Hoffman, William Stafford Noble, Jeff Bilmes, Orion J. Buske, Weiping Zhou, Shengxian Yuan, Yuan Yang, Hui Liu and Fu Yang. Their work appears in journals such as Scientific Reports, Nature Communications, Cell Death and Disease, Frontiers in Immunology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.